Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennart J van Winden

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Clinical Chemistry|June 6, 2022
Testosterone analysis in prostate cancer patientsLennart J van Winden, Huub H van Rossum
Proteomics|July 25, 2023
Towards deciphering glioblastoma intra-tumoral heterogeneity: The importance of integrating multidimensional modelsRifat Shahriar Sajid, Lennart J van Winden, Phedias Diamandis
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2018
Serum Testosterone by Liquid Chromatography Tandem Mass Spectrometry for Routine Clinical DiagnosticsLennart J van Winden, Olaf van Tellingen, Huub H van Rossum
European Urology Open Science|January 19, 2023
Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)Huub H van Rossum, Lennart J van Winden, Andries M Bergman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 5, 2021
Simultaneous analysis of E1 and E2 by LC-MS/MS in healthy volunteers: estimation of reference intervals and comparison with a conventional E2 immunoassayLennart J van Winden, Maik Kok, Manon Acda, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 2, 2022
Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancerLennart J van Winden, Mirthe Lanfermeijer, Vincent Dezentje, et al.
Urologic Oncology|November 15, 2022
Predictive value of low testosterone concentrations during and prior to enzalutamide treatment in metastatic castration-resistant prostate cancerLennart J van Winden, Mirthe Lanfermeijer, Vincent Dezentje, et al.
Analytical Biochemistry|March 2, 2024
An LC-MS/MS-based method for the simultaneous quantification of melatonin, cortisol and cortisone in salivaMirthe Lanfermeijer, Lennart J van Winden, Danielle E J Starreveld, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2021
Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specificationsLennart J van Winden, Mirthe Lanfermeijer, Annemieke C Heijboer, et al.
Journal of the Endocrine Society|May 20, 2022
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomyLennart J van Winden, Ravi F M Vermeulen, Vincent van den Noort, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Clinical Chemistry|June 6, 2022
Testosterone analysis in prostate cancer patientsLennart J van Winden, Huub H van Rossum
Proteomics|July 25, 2023
Towards deciphering glioblastoma intra-tumoral heterogeneity: The importance of integrating multidimensional modelsRifat Shahriar Sajid, Lennart J van Winden, Phedias Diamandis
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2018
Serum Testosterone by Liquid Chromatography Tandem Mass Spectrometry for Routine Clinical DiagnosticsLennart J van Winden, Olaf van Tellingen, Huub H van Rossum
European Urology Open Science|January 19, 2023
Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)Huub H van Rossum, Lennart J van Winden, Andries M Bergman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 5, 2021
Simultaneous analysis of E1 and E2 by LC-MS/MS in healthy volunteers: estimation of reference intervals and comparison with a conventional E2 immunoassayLennart J van Winden, Maik Kok, Manon Acda, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 2, 2022
Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancerLennart J van Winden, Mirthe Lanfermeijer, Vincent Dezentje, et al.
Urologic Oncology|November 15, 2022
Predictive value of low testosterone concentrations during and prior to enzalutamide treatment in metastatic castration-resistant prostate cancerLennart J van Winden, Mirthe Lanfermeijer, Vincent Dezentje, et al.
Analytical Biochemistry|March 2, 2024
An LC-MS/MS-based method for the simultaneous quantification of melatonin, cortisol and cortisone in salivaMirthe Lanfermeijer, Lennart J van Winden, Danielle E J Starreveld, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2021
Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specificationsLennart J van Winden, Mirthe Lanfermeijer, Annemieke C Heijboer, et al.
Journal of the Endocrine Society|May 20, 2022
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomyLennart J van Winden, Ravi F M Vermeulen, Vincent van den Noort, et al.
Pageof 2